Stanford University
Showing 21-40 of 1,238 Results
-
Maryam Ahmadi Shapourabadi
Social Science Research Scholar, Psychiatry and Behavioral Sciences - Sleep Medicine
Current Role at StanfordResearch Scolar
-
Jeesung Ahn
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsMy research focuses on translating neuroscience into real-world solutions by leveraging brain function as a biomarker to advance precision in depression treatment and develop personalized approaches to mental and behavioral health care.
-
Raag Airan
Associate Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Materials Science & Engineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsOur goal is to develop and clinically implement new technologies for high-precision and noninvasive intervention upon the nervous system. Every few millimeters of the brain is functionally distinct, and different parts of the brain may have counteracting responses to therapy. To better match our therapies to neuroscience, we develop techniques that allow intervention upon only the right part of the nervous system at the right time, using technologies like focused ultrasound and nanotechnology.
-
Teddy J. Akiki, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Akiki's research focuses on advancing precision psychiatry through computational neuroscience approaches. His work centers on developing transformer-based foundation models for functional neuroimaging that can predict treatment responses and symptom trajectories in psychiatric disorders. Using multimodal connectomics (combining structural, functional, and diffusion MRI), he maps neural circuits underlying stress-related conditions, with particular emphasis on identifying dysconnectivity patterns in PTSD and depression. Dr. Akiki develops novel analytical methods for neuroimaging data, including network-restricted metrics and community detection frameworks optimized for functional time series. His translational work includes neuroimaging-augmented clinical trials of novel therapeutics for treatment-resistant psychiatric disorders, with the goal of implementing data-driven, personalized interventions based on individual neurobiological profiles.
-
Amy Alexander
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsCollege Mental Health, Emotional Support Animals & Service Animals, Women's Health, Mental Health & Well-being in Veterinarians
-
Olivia Altamirano, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Altamirano is a Clinical Psychologist at Stanford University’s INSPIRE Training Program, specializing in Cognitive Behavioral Therapy for Psychosis (CBTp). She works in both outpatient and inpatient settings, with primary clinical appointments at the INSPIRE Clinic, which focuses on early psychosis, and ALMA Clinic, which serves Spanish-speaking individuals of Latin American background experiencing anxiety and mood disorders. As a native Spanish speaker, Dr. Altamirano blends her expertise in psychotic-spectrum disorders with an understanding of the cultural influences shaping Latinx/a/o clinical presentations.
Dr. Altamirano's main research and clinical interests center on cultural adaptations to psychosocial treatments for psychotic-spectrum disorders. As part of the EPI-CAL initiative, she serves as a CBTp trainer for community clinicians and provides ongoing consultation, contributing to the development of a network of early psychosis programs across California. Through Stanford’s INSPIRE Training Program, she also delivers CBTp training and consultation that extends beyond California.
Dr. Altamirano is a dedicated educator and mentor. She co-teaches the undergraduate course "Destigmatizing Psychosis: I Thought I Heard My Name," and is working to expand this course into community and graduate student settings. She serves as an academic mentor and postdoctoral supervisor within the Stanford Clinical Psychology Fellowship program, and advises graduate students in the PGSP-Stanford PsyD Consortium.
She additionally serves as the Chair of the Psychosis and Schizophrenia Spectrum Special Interest Group (PASS SIG) at the Association for Behavioral and Cognitive Therapies (ABCT) and as the co-chair of the Equity, Diversity, and Inclusion team at the North America CBTp Network. Reflecting her commitment to educational equity, Dr. Altamirano is also a Board member of the South County California Student Opportunity and Access Program (Cal-SOAP), where she supports efforts to promote higher education opportunities for underserved students—a mission informed by her own experience navigating the K-12 to higher education pipeline as a Cal-SOAP alumna. Her dedication to expanding access extends internationally: she co-taught a version of the "Destigmatizing Psychosis" course in Mexico, mentors visiting international research interns, and is actively working to develop CBTp training in Mexico, reflecting her commitment to expanding culturally responsive, evidence-based mental health care across borders. Students and colleagues interested in these efforts are encouraged to reach out. -
James Armontrout
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Armontrout is the Program Director of the Stanford Forensic Psychiatry Fellowship. He completed residency training at the Harvard Longwood Psychiatry Residency Training Program, followed by forensic psychiatry fellowship at the University of California, San Francisco. He is board certified in Psychiatry, Forensic Psychiatry, and Addiction Medicine.
Before coming to Stanford Dr. Armontrout worked as a staff psychiatrist for the Palo Alto VA Healthcare System at the Trauma Recovery Program, a residential treatment program focusing on PTSD, other trauma-related disorders, and substance use disorders. For a portion of Dr. Armontrout's time with the VA he served as the Medical Director for the Trauma Recovery Program.
In addition to his forensic fellowship activities, Dr. Armontrout currently serves as an attending in the Stanford PTSD clinic and the dual diagnosis clinic. -
Bruce Arnow, Ph.D.
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)
Current Research and Scholarly InterestsCurrent research interests include treatment outcome for major depression, particularly treatment refractory and chronic forms of major depression, as well as mediators and moderators of outcome; the epidemiology of chronic pain and depression; relationships between child maltreatment and adult sequelae, including psychiatric, medical and health care utilization.
-
Martijn Arns
Affiliate, Psychiatry and Behavioral Sciences
BioMartijn Arns, PhD, is an applied neuroscientist and entrepreneur with a longstanding focus on brain stimulation, neurofeedback/BCI, and medtech innovation, affiliated with the Stanford Brain Stimulation Lab and the Psychedelics and Consciousness Lab previously headed by Dr. Nolan Williams, dividing his time between Palo Alto and Nijmegen, the Netherlands.
In 2001, he founded the Brainclinics Foundation, a non-profit research institute dedicated to applied neuroscience from the clinic, to the clinic. His research and clinical work span interventional psychiatry, precision and stratified psychiatry, and novel interventions including rTMS for depression and OCD, TMS-induced Heart–Brain Coupling, neurofeedback, and psychedelics.
Dr. Arns has published over 190 scientific papers and holds four patents. He has successfully translated research into practice through multiple spin-off ventures. Beyond research and entrepreneurship, Dr. Arns contributes to the scientific community as associate editor for leading journals, organizer of international conferences, and board member of several professional organizations. He also advises medtech and AI start-ups and established companies, helping to advance translation and implementation in applied neuroscience. -
John Wesson Ashford Jr
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Ashford is a Clinical Professor of Psychiatry and Behavioral Sciences (affiliated) at Stanford University and has been a staff psychiatrist since 2003 and the Director of the War Related Illness and Injury Study Center (WRIISC) at the VA Palo Alto Health Care System since 2007. Dr. Ashford is a Senior Research Scientist at the Stanford / VA Aging and Alzheimer's Disease Clinical Research Centers. He is a member of the Scientific Advisory Board and Chair of the Memory Screening Advisory Board of the Alzheimer's Foundation of America, a Senior Editor of the Journal of Alzheimer's Disease, and the 14th President of the Society for Brain Mapping & Therapeutics.
Dr. Ashford obtained a BA the University of California, Berkeley in 1970. At UCLA (1970–1985) he attained an MD (1974) and PhD (1984), trained in psychiatry (1975-1979), co-founded the Neurobehavior Clinic, and was the first Chief Resident and Associate Director (1979-1980) on the Geriatric Psychiatry In-Patient Unit. He conducted the first double-blind study of an anti-cholinesterase drug (physostigmine) to treat Alzheimer patients (Ashford et al., 1981), a therapy which is now standard treatment for Alzheimer patients. Between 1980-1985, Dr. Ashford directed the Geriatric Psychiatry Out-patient Clinic at the Neuropsychiatric Institute and initiated the UCLA/Alzheimer PET scan study with Dr. David Kuhl.
Between 1979-1984 under Dr. Joaquin Fuster, Dr. Ashford completed his Ph.D. dissertation, a finalist for the Lindsley Prize for the best in Behavioral Neuroscience in 1984. With Dr. Fuster, he made the first proposal and physiologic demonstration of massive, reciprocal parallel information processing in the cerebral cortex (Ashford et al., 1985); a basis of memory, particularly that aspect of memory affected by Alzheimer’s disease (Ashford, Coburn, and Fuster, 1998). His Alzheimer and neurophysiology study led to the water-shed observation that neuroplastic memory mechanisms of the brain are specifically affected by Alzheimer pathology (Ashford & Jarvik, 1985; Ashford, 2015).
Dr. Ashford was an Assistant Professor of Psychiatry at the Southern Illinois University School of Medicine between 1985-1990, helping to establish an NIA-funded Alzheimer’s Disease Center. There he published the first use of Modern Test Theory in the field of Medicine, “Item-Response Theory” analysis of the Mini-Mental State Exam (Ashford et al., 1989). He was an Associate Professor of Psychiatry at the University of California, Davis 1991-1992, at the Martinez, VAMC, and Chief of the Mental Hygiene Clinic. He was at the University of Kentucky from 1992-2003 as a tenured Associate Professor in Psychiatry, Neurology, and the Sanders-Brown Center on Aging, and Vice-Chair for Research in the Department of Psychiatry, where he continued his Alzheimer research. He proposed a “Time-Index” method to measure Alzheimer dementia severity (Ashford et al., 1995; Ashford & Schmitt, 2001), used in the UK Nun Study (Butler, Ashford, Snowden, 1996), and to study loss of cerebral perfusion in Alzheimer patients (Ashford et al., 2000). With Dr. James Geddes he showed the central role of paired helical filament pathology in destroying neuronal processes (Ashford et al., 1998).
Dr. Ashford’s long-term research interests are aging, Alzheimer’s disease, brain imaging, and memory mechanisms. He has developed early detection and measurement methods for mild cognitive disorders and Alzheimer’s disease, currently working on an internet program: www.memtrax.com . He is reformulating theories of Alzheimer pathology. As Director of WRIISC CA, he has studied traumatic brain injury, post-traumatic stress disorder, chronic pain, chronic multi-symptom illness, and other neuropsychiatric illnesses.
Complete List of Published Work in MyBibliography: (140 references)
https://www.ncbi.nlm.nih.gov/sites/myncbi/john.ashford.1/bibliography/48071896/public/?sort=date&direction=descending
